| scholarly article | Q13442814 |
| P2093 | author name string | Goudsmit J | |
| Cornelissen M | |||
| Lukashov V | |||
| Zorgdrager F | |||
| van den Burg R | |||
| P2860 | cites work | Retroviral Recombination and Reverse Transcription | Q22242273 |
| Recombination in AIDS viruses | Q22252829 | ||
| 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro | Q24609215 | ||
| A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences | Q27860580 | ||
| Site-specific mutagenesis of AIDS virus reverse transcriptase | Q28338101 | ||
| Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor | Q28379356 | ||
| Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection | Q29547852 | ||
| Viral dynamics in human immunodeficiency virus type 1 infection | Q29547908 | ||
| Rapid and simple method for purification of nucleic acids | Q29615124 | ||
| HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy | Q29616404 | ||
| Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase | Q29619994 | ||
| In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors | Q29620622 | ||
| Convergent evolution within the V3 loop domain of human immunodeficiency virus type 1 in association with disease progression | Q30416671 | ||
| Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization. | Q30423779 | ||
| Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy | Q35828466 | ||
| Dual human immunodeficiency virus type 1 infection and recombination in a dually exposed transfusion recipient. The Transfusion Safety Study Group. | Q35839373 | ||
| In vivo sequence diversity of the protease of human immunodeficiency virus type 1: presence of protease inhibitor-resistant variants in untreated subjects. | Q35857907 | ||
| Human immunodeficiency virus fitness in vivo: calculations based on a single zidovudine resistance mutation at codon 215 of reverse transcriptase | Q35866696 | ||
| Increased envelope spike density and stability are not required for the neutralization resistance of primary human immunodeficiency viruses | Q35868205 | ||
| The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin | Q35870667 | ||
| Quantitation of zidovudine-resistant human immunodeficiency virus type 1 in the blood of treated and untreated patients | Q36024504 | ||
| Identification of human immunodeficiency virus type 1 envelope genes recombinant between subtypes B and F in two epidemiologically linked individuals from Brazil. | Q36635996 | ||
| Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient | Q37031589 | ||
| Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination | Q37701269 | ||
| Structure, Replication, and Recombination of Retrovirus Genomes: Some Unifying Hypotheses | Q37875366 | ||
| Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1. | Q38357781 | ||
| Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization | Q38889266 | ||
| The World Health Organization Global Programme on AIDS proposal for standardization of HIV sequence nomenclature. WHO Network for HIV Isolation and Characterization | Q38889282 | ||
| Genetic variants of HIV-1 in Thailand | Q39234678 | ||
| Intrahost human immunodeficiency virus type 1 evolution is related to length of the immunocompetent period | Q39872343 | ||
| Human immunodeficiency virus type 1 subtypes defined by env show high frequency of recombinant gag genes. The UNAIDS Network for HIV Isolation and Characterization | Q39877061 | ||
| HIV protease inhibitors | Q41179708 | ||
| Ordered accumulation of mutations in HIV protease confers resistance to ritonavir | Q42555782 | ||
| Extensive regions of pol are required for efficient human immunodeficiency virus polyprotein processing and particle maturation. | Q45770989 | ||
| Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects | Q45873929 | ||
| Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays. | Q46964850 | ||
| Primary infections with HIV-1 of women and their offspring in Rwanda: findings of heterogeneity at seroconversion, coinfection, and recombinants of HIV-1 subtypes A and C. | Q48055091 | ||
| Biological and molecular characterization of subtype D, G, and A/D recombinant HIV-1 transmissions in Sweden | Q48073755 | ||
| Recombination in HIV-1 | Q57998149 | ||
| Complete mutagenesis of the HIV-1 protease | Q59066144 | ||
| Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand | Q64135772 | ||
| Wide distribution of two subtypes of HIV-1 in Thailand | Q67967870 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | drug resistance | Q12147416 |
| P304 | page(s) | 6348-6358 | |
| P577 | publication date | 1997-09-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | pol gene diversity of five human immunodeficiency virus type 1 subtypes: evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D | |
| P478 | volume | 71 |
| Q35742512 | A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies |
| Q60218432 | A Hybrid Structure/Pharmacophore-Based Virtual Screening Approach to Design Potential Leads: A Computer-Aided Design of South African HIV-1 Subtype C Protease Inhibitors |
| Q45746006 | An unusual HIV type 1 env sequence embedded in a mosaic virus from Cameroon: identification of a new env clade. European Network on the study of in utero transmission of HIV-1. |
| Q36841895 | Analysis of HIV-1 CRF_01 A/E protease inhibitor resistance: structural determinants for maintaining sensitivity and developing resistance to atazanavir |
| Q44574387 | Analysis of the protease sequences of HIV-1 infected individuals after Indinavir monotherapy |
| Q36083803 | Association between different anti-Tat antibody isotypes and HIV disease progression: data from an African cohort |
| Q33930297 | Broad cross-clade T-cell responses to gag in individuals infected with human immunodeficiency virus type 1 non-B clades (A to G): importance of HLA anchor residue conservation |
| Q56935562 | CTL escape and increased viremia irrespective of HIV-specific CD4+ T-helper responses in two HIV-infected individuals |
| Q35927934 | Catalytic efficiency and vitality of HIV-1 proteases from African viral subtypes |
| Q47402074 | Characterization of HIV Type 1 Clades in the Caribbean UsingpolGene Sequences |
| Q38882653 | Characterization of novel recombinant HIV-1 genomes using the branching index |
| Q28539169 | Comparable long-term efficacy of Lopinavir/Ritonavir and similar drug-resistance profiles in different HIV-1 subtypes |
| Q34465489 | Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C. |
| Q39448983 | Comparison of human immunodeficiency virus type 1 (HIV-1) protease mutations in HIV-1 genomes detected in plasma and in peripheral blood mononuclear cells from patients receiving combination drug therapy |
| Q24814895 | Conservation of functional domains and limited heterogeneity of HIV-1 reverse transcriptase gene following vertical transmission |
| Q33787173 | Convergent evolution of reverse transcriptase (RT) genes of human immunodeficiency virus type 1 subtypes E and B following nucleoside analogue RT inhibitor therapies |
| Q35857522 | Cross-clade inhibition of recombinant human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus SIVcpz reverse transcriptases by RNA pseudoknot aptamers |
| Q34034454 | Developing and evaluating comprehensive HIV infection control strategies: issues and challenges |
| Q30011040 | Different epidemic potentials of the HIV-1B and C subtypes |
| Q41766427 | Diminished replicative fitness of primary human immunodeficiency virus type 1 isolates harboring the K65R mutation |
| Q46121038 | Drug-resistant molecular mechanism of CRF01_AE HIV-1 protease due to V82F mutation |
| Q44582874 | Epidemiology of HIV-1 and emerging problems |
| Q33865608 | Evolutionary relationships among parvoviruses: virus-host coevolution among autonomous primate parvoviruses and links between adeno-associated and avian parvoviruses |
| Q34066537 | Frequent polymorphism at drug resistance sites in HIV-1 protease and reverse transcriptase |
| Q57019978 | Functional conservation and coherence of HIV-1 subtype A Vpu alleles |
| Q33670199 | Functional conservation and coherence of HIV-1 subtype A Vpu alleles. |
| Q42557274 | Genetic Analysis of a UNAIDS HIV Type 1 from Brazil Revealed an Unexpected Recombination Pattern |
| Q34110204 | Genetic divergence of human immunodeficiency virus type 1 Ethiopian clade C reverse transcriptase (RT) and rapid development of resistance against nonnucleoside inhibitors of RT. |
| Q39461924 | Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: evidence of many minor drug resistance mutations in treatment-naive patients |
| Q33906239 | Genotypic testing for human immunodeficiency virus type 1 drug resistance |
| Q33834118 | HIV protease: enzyme function and drug resistance |
| Q46194250 | HIV-1 proteases from drug-naive West African patients are differentially less susceptible to protease inhibitors |
| Q37110723 | Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals. |
| Q37059821 | Identification of Sequential Viral Escape Mutants Associated with Altered T-Cell Responses in a Human Immunodeficiency Virus Type 1-Infected Individual |
| Q34346614 | In vitro intersubtype recombinants of human immunodeficiency virus type 1: comparison to recent and circulating in vivo recombinant forms |
| Q81781506 | Infection of human and non-human cells by a highly fusogenic primary CD4-independent HIV-1 isolate with a truncated envelope cytoplasmic tail |
| Q28290133 | LTR and tat variability of HIV-1 isolates from patients with divergent rates of disease progression |
| Q37366730 | Lack of in vivo compartmentalization among HIV-1 infected naïve and memory CD4+ T cell subsets |
| Q36933330 | Low-Frequency Drug Resistance in HIV-Infected Ugandans on Antiretroviral Treatment Is Associated with Regimen Failure. |
| Q39454015 | Mutation patterns of the reverse transcriptase and protease genes in human immunodeficiency virus type 1-infected patients undergoing combination therapy: survey of 787 sequences |
| Q40363090 | Mutations other than 103N in human immunodeficiency virus type 1 reverse transcriptase (RT) emerge from K103R polymorphism under non-nucleoside RT inhibitor pressure |
| Q34490344 | Population dynamics of HIV-1 inferred from gene sequences. |
| Q34416398 | Rational development of prophylactic HIV vaccines based on structural and regulatory proteins |
| Q34933329 | Replicative fitness costs of nonnucleoside reverse transcriptase inhibitor drug resistance mutations on HIV subtype C. |
| Q39559316 | Resistance to human immunodeficiency virus type 1 protease inhibitors. |
| Q42159090 | Reverse transcriptase backbone can alter the polymerization and RNase activities of non-nucleoside reverse transcriptase mutants K101E+G190S. |
| Q42348438 | Sensitivity changes over the course of infection increases the likelihood of resistance against fusion but not CCR5 receptor blockers. |
| Q47936109 | Sequence analysis of the polymerase domain of HIV-1 reverse transcriptase in naive and zidovudine-treated individuals reveals a higher polymorphism in alpha-helices as compared with beta-strands. |
| Q33977153 | Sequence diversity of the reverse transcriptase of human immunodeficiency virus type 1 from untreated Brazilian individuals. |
| Q37550353 | Short Communication: Analysis of Selection Pressure and Mutational Pattern of HIV Type 1 Reverse Transcriptase Region Among Treated and Nontreated Patients |
| Q34989641 | Testing genotypic and phenotypic resistance in human immunodeficiency virus type 1 isolates of clade B and other clades from children failing antiretroviral therapy |
| Q37018369 | The Genetic Basis of HIV-1 Resistance to Reverse Transcriptase and Protease Inhibitors. |
| Q30425595 | The challenge of HIV-1 antiretroviral resistance in Africa in the era of HAART. |
| Q33567164 | Transmitted drug resistance in nonsubtype B HIV-1 infection |
| Q31009699 | Use of sequence data generated in the Bayer Tru Gene genotyping assay to recognize and characterize non-subtype-b human immunodeficiency virus type 1 strains |
Search more.